Comarit (Cabozantinib, L01XE26) is a tyrosine kinase inhibitor, indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). Cabozantinib (Cometriq, L01XE26) inhibits the kinase activity of certain receptors that are responsible for various pathological processes such as oncogenesis, metastasis, tumor angiogenesis, drug resistance, and maintenance of the tumor microenvironment. Comarit is the Cometriq generic. Comarit manufactured by Genvio Pharma Limited. Genvio is one of the top anticancer medicine manufacturer in Bangladesh. Comarit is the generic brand of Cometriq (Cabozantinib) at an affordable price.